Terms: = Gastric cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
1662 results:
1. Hyponutrition among newly diagnosed gastric cancer.
Pham VT; Nguyen MLT; Pham C; LE QV; Tran DH; LE TS; Nguyen LT; Bui KC
Bratisl Lek Listy; 2024; 125(6):392-398. PubMed ID: 38757598
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced gastric cancer.
Yamaguchi K; Ito M; Isobe T; Koreishi S; Taguchi R; Uehara K; Ueno S; Imajima T; Kitazono T; Tsuchihashi K; Ohmura H; Yoshihiro T; Tanoue K; Nishiyori S; Iwama E; Maeda T; Akashi K; Baba E
JCO Precis Oncol; 2024 May; 8():e2300681. PubMed ID: 38748981
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysis.
Wu D; Yang L; Yan Y; Jiang Z; Liu Y; Dong P; Lv Y; Zhou S; Qiu Y; Yu X
Cancer Med; 2024 May; 13(9):e7176. PubMed ID: 38716645
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics of early gastric tumors with different differentiation and predictors of long-term outcomes after endoscopic submucosal dissection.
Zhu HY; Wu J; Zhang YM; Li FL; Yang J; Qin B; Jiang J; Zhu N; Chen MY; Zou BC
World J Gastroenterol; 2024 Apr; 30(14):1990-2005. PubMed ID: 38681129
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract] [Full Text] [Related]
6. The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis.
Cai X; Li X; Liang C; Zhang M; Dong Z; Yu W
Sci Rep; 2024 Apr; 14(1):9474. PubMed ID: 38658636
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China.
Liu W; Zhou D; Zhang L; Huang M; Quan R; Xia R; Ye Y; Zhang G; Shen Z;
J Cancer Res Clin Oncol; 2024 Apr; 150(4):205. PubMed ID: 38642154
[TBL] [Abstract] [Full Text] [Related]
8. Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
Wakatsuki T; Ishizuka N; Hironaka S; Minashi K; Kadowaki S; Goto M; Shoji H; Hirano H; Nakayama I; Osumi H; Ogura M; Chin K; Yamaguchi K; Takahari D
Int J Clin Oncol; 2024 Jun; 29(6):801-812. PubMed ID: 38589679
[TBL] [Abstract] [Full Text] [Related]
9. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract] [Full Text] [Related]
10. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal cancer: Results of a Population-Based Retrospective Cohort Analysis.
Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study.
Demirci NS; Azizy A; Paksoy N; Doğan İ; Karabulut S; Karahan L; Tastekin D
Medicine (Baltimore); 2024 Mar; 103(9):e37259. PubMed ID: 38428877
[TBL] [Abstract] [Full Text] [Related]
12. Real-time Histological Evaluation of gastric cancer Tissue by Using a Confocal Laser Endomicroscopic System.
Bae H; Cho H; Jo Y; Heo SM; Chu J; Choi S; Hwang K; Kim K; Kim S
In Vivo; 2024; 38(2):855-863. PubMed ID: 38418139
[TBL] [Abstract] [Full Text] [Related]
13. A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
Tirgar Fakheri S; Shokri-Afra H; Graham DY; Bari Z; Fakheri H
Helicobacter; 2024; 29(1):e13061. PubMed ID: 38411303
[TBL] [Abstract] [Full Text] [Related]
14. Optimal extent of lymph node dissection for high-risk gastric cancer stratified by a national clinical database risk calculator.
Kuroda K; Miki Y; Kasashima H; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Toyokawa T; Lee S; Maeda K
World J Surg; 2024 May; 48(5):1198-1208. PubMed ID: 38391091
[TBL] [Abstract] [Full Text] [Related]
15. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
16. Helicobacter pylori Eradication treatment in Older Patients.
Jonaitis P; Kupcinskas J; Gisbert JP; Jonaitis L
Drugs Aging; 2024 Feb; 41(2):141-151. PubMed ID: 38340290
[TBL] [Abstract] [Full Text] [Related]
17. Oncological outcomes of sequential laparoscopic gastrectomy after treatment with camrelizumab combined with nab-paclitaxel plus S-1 for gastric cancer with serosal invasion.
Lin JL; Lin M; Lin GT; Zhong Q; Lu J; Zheng CH; Xie JW; Wang JB; Huang CM; Li P
Front Immunol; 2024; 15():1322152. PubMed ID: 38333217
[TBL] [Abstract] [Full Text] [Related]
18. [Successful eradication rate of Helicobacter pylori with empirical antibiotic treatment in pediatric patients from a Tertiary Hospital].
Darritchon Lama S; Díaz García D; Toledo Cumplido M; Lucero Álvarez Y
Andes Pediatr; 2023 Dec; 94(6):721-728. PubMed ID: 38329308
[TBL] [Abstract] [Full Text] [Related]
19. PALLIATIVE GASTRECTOMY VERSUS gastric BYPASS FOR SYMPTOMATIC CLINICAL STAGE IV gastric cancer: A PROPENSITY SCORE MATCHING ANALYSIS.
Pinto SOSA; Pereira MA; Ribeiro Junior U; D'Albuquerque LAC; Ramos MFKP
Arq Bras Cir Dig; 2024; 36():e1790. PubMed ID: 38324851
[TBL] [Abstract] [Full Text] [Related]
20. Success of susceptibility-guided eradication of
Wang YM; Chen MY; Chen J; Zhang XH; Feng Y; Han YX; Li YL
World J Gastroenterol; 2024 Jan; 30(2):184-195. PubMed ID: 38312120
[TBL] [Abstract] [Full Text] [Related]
[Next]